“…Aberrant methylation of this locus in noncancer controls has not been detected [23–25]. A panel of cell lines was investigated for homozygous deletion, hypermethylation, and point mutations at p16 , with results indicating that the first two alteration types were the more common modes of p16 disruption in OSCC [26]. …”
Section: Genes Evincing Methylation Changes In Oral Squamous Cell mentioning
Herein we provide a concise review of the state of methylation research as it pertains to clinical oral cancerous and precancerous tissues. We provide context for ongoing research efforts in this field and describe technologies that are presently being applied to analyze clinical specimens. We also discuss the various recurrent methylation changes that have been reported for oral malignancy (including those genes frequently silenced by promoter methylation and the small RNAs with activity modulated by methylation changes) and describe surrogate disease markers identified via epigenetic analysis of saliva and blood specimens from patients with oral cancer.
“…Aberrant methylation of this locus in noncancer controls has not been detected [23–25]. A panel of cell lines was investigated for homozygous deletion, hypermethylation, and point mutations at p16 , with results indicating that the first two alteration types were the more common modes of p16 disruption in OSCC [26]. …”
Section: Genes Evincing Methylation Changes In Oral Squamous Cell mentioning
Herein we provide a concise review of the state of methylation research as it pertains to clinical oral cancerous and precancerous tissues. We provide context for ongoing research efforts in this field and describe technologies that are presently being applied to analyze clinical specimens. We also discuss the various recurrent methylation changes that have been reported for oral malignancy (including those genes frequently silenced by promoter methylation and the small RNAs with activity modulated by methylation changes) and describe surrogate disease markers identified via epigenetic analysis of saliva and blood specimens from patients with oral cancer.
“…The formation of the newly generated RNA molecules can therefore be determined in real time by continuous monitoring of fluorescence in a Lambda Fluoro 320 reader (MWG Biotech, AG, Ebersberg, Germany). The PreTect HPV-Proofer Kit includes specific primer and molecular beacon probe sets for detection and simultaneous typing of 2 of the high-risk HPV types [14,16]. The PreTect HPV Proofer Kit also contains a primer and probe set for U1A, which is used as an extraction control.…”
Section: Detection Of Hpv 16/18 Rnamentioning
confidence: 99%
“…Alterations of the p16 tumor suppressor gene have been consistently reported in HNSCC, with the prevalence of p16 alterations ranging from 25% to 83% [8][9][10][11][12]. Previous studies have noted that these alterations are predominantly in the form of deletions and methylationinduced epigenetic silencing, and also, that mutation of p16 is a less common mechanism of inactivation in head and neck cancer [13][14][15]. Previous work by this group has specifically noted that p16 deletions in HNSCC occurred in patients older than 40 years [10].…”
“…For DNA methylation analysis, sodium bisulfite modification of genomic DNA was performed, as described previously (Grunau et al, 2001;Lehmann et al, 2001;Lee et al, 2004). In brief, 1 µg DNA was denatured with 0.2 M NaOH in a total vol of 50 µl.…”
Section: Dna Methylation Analysis Of the Runx3 Genementioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.